BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 15505021)

  • 1. Decreasing restenosis following angioplasty: the potential of peroxisome proliferator-activated receptor gamma agonists.
    Fonseca VA; Diez J; McNamara DB
    Diabetes Care; 2004 Nov; 27(11):2764-6. PubMed ID: 15505021
    [No Abstract]   [Full Text] [Related]  

  • 2. Upregulation of peroxisome proliferator-activated receptor-gamma and NADPH oxidases are involved in restenosis after balloon injury.
    Qin HD; Huang D; Weng XD; Xu F
    J Cell Physiol; 2009 Nov; 221(2):387-93. PubMed ID: 19562688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fighting restenosis - never-ending story].
    Przewłocki T
    Kardiol Pol; 2010 Sep; 68(9):994-5. PubMed ID: 20859887
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prevention of postangioplasty restenosis].
    Kitai T; Ishiwata S; Yamaguchi T
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():627-31. PubMed ID: 12735042
    [No Abstract]   [Full Text] [Related]  

  • 5. Restenosis following thin-strut bare-metal stents versus thick-strut drug-eluting stents.
    Moliterno DJ
    Catheter Cardiovasc Interv; 2007 May; 69(6):799-800. PubMed ID: 17377984
    [No Abstract]   [Full Text] [Related]  

  • 6. In-stent restenosis: 3 novel solutions show promise for heart patients. Stopping regrowth of plaque inside stents is a priority in reducing the need for repeat revascularizations.
    Duke Med Health News; 2007 Mar; 13(3):3-4. PubMed ID: 17385240
    [No Abstract]   [Full Text] [Related]  

  • 7. Management of drug-eluting stent restenosis.
    Ishikawa K; Aoyama Y; Hirayama H
    J Invasive Cardiol; 2012 Apr; 24(4):178-82. PubMed ID: 22477755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Palmaz-Schatz stent].
    Kobayashi N; Yamaguchi T
    Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):947-53. PubMed ID: 12436643
    [No Abstract]   [Full Text] [Related]  

  • 9. Introduction: glycoprotein IIb/IIIa blockers in the era of metallic coronaries.
    Goldschmidt-Clermont PJ
    J Invasive Cardiol; 2002 Dec; 14 Suppl E():1E. PubMed ID: 12668856
    [No Abstract]   [Full Text] [Related]  

  • 10. [Restenosis after coronary angioplasty: pathomechanism and potential targets for therapeutic intervention. Focus on inflammation].
    Koziński M; Sukiennik A; Rychter M; Kubica J; Sinkiewicz W
    Postepy Hig Med Dosw (Online); 2007; 61():58-73. PubMed ID: 17369774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current status of coronary stent].
    Nobuyoshi M; Kimura T
    Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):934-41. PubMed ID: 12436641
    [No Abstract]   [Full Text] [Related]  

  • 12. Catheter entrapment during balloon angioplasty in patient with in-stent restenosis: an unusual complication and its surgical management.
    Goksin I; Baltalarli A; Semiz E; Gurses E; Sacar M; Ozcan V; Sungurtekin H
    J Card Surg; 2007; 22(2):160-2. PubMed ID: 17338758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coated stents for the prevention of restenosis: Part I.
    Babapulle MN; Eisenberg MJ
    Circulation; 2002 Nov; 106(21):2734-40. PubMed ID: 12438301
    [No Abstract]   [Full Text] [Related]  

  • 14. New technologies in percutaneous coronary interventions: drug-coated balloons.
    Kleber FX; Scheller B; Serruys PW
    EuroIntervention; 2011 May; 7 Suppl K():K7. PubMed ID: 22027732
    [No Abstract]   [Full Text] [Related]  

  • 15. [Self-expanding stent].
    Kadota K; Mitsudo K
    Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):942-6. PubMed ID: 12436642
    [No Abstract]   [Full Text] [Related]  

  • 16. Stenting small vessels? Not a small issue.
    Bass TA
    Catheter Cardiovasc Interv; 2004 Aug; 62(4):430-1. PubMed ID: 15274149
    [No Abstract]   [Full Text] [Related]  

  • 17. A cagey proposition.
    Ho YD; Lee DP
    J Invasive Cardiol; 2008 Jan; 20(1):28. PubMed ID: 18174615
    [No Abstract]   [Full Text] [Related]  

  • 18. Engineering a bioresorbable stent: REVA programme update.
    Pollman MJ
    EuroIntervention; 2009 Dec; 5 Suppl F():F54-7. PubMed ID: 22100677
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention of restenosis with antioxidants: mechanisms and implications.
    Tardif JC; Grégoire J; L'Allier PL
    Am J Cardiovasc Drugs; 2002; 2(5):323-34. PubMed ID: 14727962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelets and endothelium: two key players in percutaneous coronary intervention.
    Bonello L; Sabatier F; Camoin-Jau L; Paganelli F; Dignat-George F
    Arch Cardiovasc Dis; 2011 Dec; 104(12):601-3. PubMed ID: 22152511
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.